These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27930879)

  • 1. Melanoma exosomes deliver a complex biological payload that upregulates PTPN11 to suppress T lymphocyte function.
    Wu Y; Deng W; McGinley EC; Klinke DJ
    Pigment Cell Melanoma Res; 2017 Mar; 30(2):203-218. PubMed ID: 27930879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes derived from B16F0 melanoma cells alter the transcriptome of cytotoxic T cells that impacts mitochondrial respiration.
    Bland CL; Byrne-Hoffman CN; Fernandez A; Rellick SL; Deng W; Klinke DJ
    FEBS J; 2018 Mar; 285(6):1033-1050. PubMed ID: 29399967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity.
    Näslund TI; Gehrmann U; Qazi KR; Karlsson MC; Gabrielsson S
    J Immunol; 2013 Mar; 190(6):2712-9. PubMed ID: 23418627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
    Xie Y; Bai O; Zhang H; Li W; Xiang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.
    Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S
    Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of cytolytic CD8+ T cells in B16-melanoma and proliferation of mature T cells in TIS21-knockout mice after T cell receptor stimulation.
    Ryu MS; Woo MY; Kwon D; Hong AE; Song KY; Park S; Lim IK
    Exp Cell Res; 2014 Oct; 327(2):209-21. PubMed ID: 25088256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Lymphocyte Subsets in the Immune Response to Primary B Cell-Derived Exosomes.
    Saunderson SC; McLellan AD
    J Immunol; 2017 Oct; 199(7):2225-2235. PubMed ID: 28842467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated T cell exosomes promote tumor invasion via Fas signaling pathway.
    Cai Z; Yang F; Yu L; Yu Z; Jiang L; Wang Q; Yang Y; Wang L; Cao X; Wang J
    J Immunol; 2012 Jun; 188(12):5954-61. PubMed ID: 22573809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel T-cell-based vaccines via arming polyclonal CD4
    Xu A; Freywald A; Xiang J
    Immunotherapy; 2016 Nov; 8(11):1265-1269. PubMed ID: 27993084
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrophages play an essential role in antigen-specific immune suppression mediated by T CD8⁺ cell-derived exosomes.
    Nazimek K; Ptak W; Nowak B; Ptak M; Askenase PW; Bryniarski K
    Immunology; 2015 Sep; 146(1):23-32. PubMed ID: 25808106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma.
    Vignard V; Labbé M; Marec N; André-Grégoire G; Jouand N; Fonteneau JF; Labarrière N; Fradin D
    Cancer Immunol Res; 2020 Feb; 8(2):255-267. PubMed ID: 31857348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes.
    Hao S; Bai O; Yuan J; Qureshi M; Xiang J
    Cell Mol Immunol; 2006 Jun; 3(3):205-11. PubMed ID: 16893501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
    Cekic C; Day YJ; Sag D; Linden J
    Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.
    Wang L; Xie Y; Ahmed KA; Ahmed S; Sami A; Chibbar R; Xu Q; Kane SE; Hao S; Mulligan SJ; Xiang J
    Breast Cancer Res Treat; 2013 Jul; 140(2):273-84. PubMed ID: 23881522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node.
    Cheng L; Wang Y; Huang L
    Mol Ther; 2017 Jul; 25(7):1665-1675. PubMed ID: 28284981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy.
    Mittal P; St Rose MC; Wang X; Ryan JM; Wasser JS; Vella AT; Adler AJ
    J Immunol; 2015 Dec; 195(12):5816-26. PubMed ID: 26561553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal cancer immunotherapy is independent of MHC molecules on exosomes.
    Hiltbrunner S; Larssen P; Eldh M; Martinez-Bravo MJ; Wagner AK; Karlsson MC; Gabrielsson S
    Oncotarget; 2016 Jun; 7(25):38707-38717. PubMed ID: 27231849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].
    Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.